All Stories

  1. Recurrent integration of domestic cat hepatitis B virus DNA near feline CCNE1 supports an oncogenic role in hepatocellular carcinoma in cats
  2. Patient and public health perspectives to inform expansion of hepatitis B treatment guidelines
  3. Scientific and medical evidence informing expansion of hepatitis B treatment guidelines
  4. Let's break it down: combating hepatitis stigma and discrimination
  5. Sexual health and young people living with chronic hepatitis B: adopting a treatment as prevention framework
  6. Domestic Cat Hepadnavirus, a Hepatitis B-like Virus Associated with Feline Liver Disease
  7. Demographic factors, knowledge, and experiences associated with engagement in care in Australians diagnosed with hepatitis B
  8. Domestic cat hepadnavirus is detected infrequently in feline blood and liver samples submitted for diagnostic testing in Texas, USA
  9. Twelfth scientific biennial meeting of the Australasian Virology Society: AVS12 2024
  10. Best practices for engaging with affected communities: chronic hepatitis B as a case study
  11. The urgent need to end hepatitis B stigma and discrimination
  12. Novel digital droplet inverse PCR assay shows that natural clearance of hepatitis B infection is associated with fewer viral integrations
  13. HBV‐Induced Carcinogenesis: Mechanisms, Correlation With Viral Suppression, and Implications for Treatment
  14. Perspectives of People Living With Chronic Hepatitis D: Impact of Disease and Unmet Needs Along the Care Cascade
  15. Hepatitis B Viral Protein HBx: Roles in Viral Replication and Hepatocarcinogenesis
  16. Major open questions in the hepatitis B and D field – Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop
  17. Peer support for people living with hepatitis B virus—A foundation for treatment expansion
  18. Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus
  19. Quality of life of people living with chronic hepatitis B: The role of social support system
  20. Hepatitis B Virus and Hepatitis C Virus Affect Mitochondrial Function Through Different Metabolic Pathways, Explaining Virus-Specific Clinical Features of Chronic Hepatitis
  21. Inhibition of Cellular Factor TM6SF2 Suppresses Secretion Pathways of Hepatitis B, Hepatitis C, and Hepatitis D Viruses
  22. Reply to Piewbang et al. Domestic Cat Hepadnavirus Antigens in Lymphoma Tissues. Comment on “Beatty et al. Domestic Cat Hepadnavirus and Lymphoma. Viruses 2023, 15, 2294”
  23. Domestic Cat Hepadnavirus and Pathogenic Retroviruses; A Sero-Molecular Survey of Cats in Santiago, Chile
  24. Letter to the Editor: Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game?
  25. Domestic Cat Hepadnavirus and Lymphoma
  26. Special Issue “Hepatitis B Virus: New Breakthroughs to Conquer an Ancient Disease”
  27. Targeting Hepatitis B Virus DNA Using Designer Gene Editors
  28. Novel Assays to Solve the Clinical and Scientific Challenges of Chronic Hepatitis B
  29. Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”
  30. Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”
  31. Targeting liver metabolism: a pathway to cure hepatitis B virus?
  32. Statement in Support of: “Virology under the Microscope—a Call for Rational Discourse”
  33. Pathway to global elimination of hepatitis B: HBV cure is just the first step
  34. Inhibition of cellular factor TM6SF2 suppresses secretion pathways of Hepatitis B, Hepatitis C and Hepatitis D viruses
  35. Domestic Cat Hepadnavirus: Molecular Epidemiology and Phylogeny in Cats in Hong Kong
  36. Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus
  37. Prevalence and Genomic Sequence Analysis of Domestic Cat Hepadnavirus in the United States
  38. Mitosis of hepatitis B virus-infected cells in vitro results in uninfected daughter cells
  39. Stigma: a major barrier to hepatitis B elimination
  40. Long-term hepatitis B virus infection of rhesus macaques requires suppression of host immunity
  41. Surrogate Markers for Hepatitis B Virus Covalently Closed Circular DNA
  42. Approaches to quantifying hepatitis B virus covalently closed circular DNA
  43. Viral integrations in chronic hepatitis B infection: Purposeless passenger or problematic promoter of persistence?
  44. A River From the Liver: Detecting Hepatocyte Genomic DNA in Urine
  45. The Inaugural Australian Centre for Hepatitis Virology Public Panel Discussion on Viral Hepatitis Research—Lessons in Scientific Community Outreach
  46. Viral Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Occurrence and Recurrence
  47. De novo synthesis of hepatitis B virus nucleocapsids is dispensable for the maintenance and transcriptional regulation of cccDNA
  48. Hepatitis B Virus DNA Integration: In Vitro Models for Investigating Viral Pathogenesis and Persistence
  49. A sensitive and Specific PCR-based Assay to Quantify Hepatitis B Virus Covalently Closed Circular (ccc) DNA While Preserving Cellular DNA
  50. Special Issue “Hepatitis B Virus Infection: From Diagnostics to Treatments”
  51. A novel method to precisely quantify hepatitis B virus covalently closed circular (ccc)DNA formation and maintenance
  52. The evolution and clinical impact of hepatitis B virus genome diversity
  53. The Lived Experience of Chronic Hepatitis B: A Broader View of Its Impacts and Why We Need a Cure
  54. Virus Genotype-Dependent Transcriptional Alterations in Lipid Metabolism and Inflammation Pathways in the Hepatitis C Virus-infected Liver
  55. Generation and characterization of a stable cell line persistently replicating and secreting the human hepatitis delta virus
  56. Analyse chromosomal integrierter HBV-DNA durch inverse nested PCR
  57. Journal Watch: Dr Tu looks back at the most important research articles released in 2018 relating to models and biomarkers of hepatocellular carcinoma
  58. Hepatitis B virus (HBV) DNA integration is not driven by viral proteins
  59. Detection of Low Copy Number Integrated Viral DNA Formed by <em>In Vitro</em> Hepatitis B Infection
  60. Detection of Low Copy Number Integrated Viral DNA Formed by <em>In Vitro</em> Hepatitis B Infection
  61. Sequence analysis of integrated hepatitis B virus DNA during HBeAg-seroconversion
  62. Cellular Genomic Sites of Hepatitis B Virus DNA Integration
  63. Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections
  64. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon
  65. Hepatitis B virus integration into cellular genome
  66. HBV bypasses the innate immune system and does not protect HCV against the antiviral effect of IFN
  67. HBV DNA Integration: Molecular Mechanisms and Clinical Implications
  68. Chronic viral hepatitis and its association with liver cancer
  69. Integrated analysis of exosomal microRNA, gene, and pathway regulatory networks in fibrosis and hepatocarcinogenesis
  70. Viral Hepatitis
  71. Whole genome sequencing analysis of familial primary sclerosing cholangitis
  72. Detection of Hepatocyte Clones Containing Integrated Hepatitis B Virus DNA Using Inverse Nested PCR
  73. Basic Science Liver
  74. Accumulation of Deleterious Passenger Mutations Is Associated with the Progression of Hepatocellular Carcinoma
  75. Abstracts of the 25th Annual Conference of APASL, February 20–24, 2016, Tokyo, Japan
  76. Differential Microrna Expression in Plasma Microvesicles Predict Hepatocellular Carcinoma Regulatory Pathways
  77. Multi-Omics Landscape of Precancerous Liver Disease
  78. Hepatocytes in liver injury: Victim, bystander, or accomplice in progressive fibrosis?
  79. Analysis of Post-Liver Transplant Hepatitis C Virus Recurrence Using Serial Cluster of Differentiation Antibody Microarrays
  80. Basic Science - Liver
  81. P0268 : Accumulation of deleterious passenger mutations during liver injury progression to hepatocellular carcinoma
  82. Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma
  83. Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection
  84. Our experts highlight the most important research articles across the spectrum of topics relevant to the field of hepatic oncology
  85. Poster Presentation Abstracts
  86. Hepatocyte Produced Matrix Metalloproteinases Are Regulated by CD147 in Liver Fibrogenesis
  87. Novel Aspects of the Liver Microenvironment in Hepatocellular Carcinoma Pathogenesis and Development
  88. Advances in and the future of treatments for hepatitis C
  89. Endoscopy Upper
  90. “Testing your methyl”: DNA methylation profiling of serum DNA of HCC patients